Pfizer says US court reverses earlier ruling upholding Norvasc patent UPDATE |
|
|
|
Published
:
Thu, 22 Mar 2007 19:34
|
(Adds detail)LONDON (AFX) - Pharmaceutical group Pfizer Inc said a US appeals court has reversed a lower court ruling that upheld the company's US patent covering amlodipine besylate, the active ingredient in the popular high blood pressure medication Norvasc.Pfizer said it is reviewing the decision by the Court of Appeals for the Federal Circuit and is considering all its options, including seeking a reconsideration.The company said generic drug maker Apotex filed the appeal after a lower court in the Northern District of Illinois had ruled that the patentwas valid and enforceable.'Pfizer disagrees with this decision. The company noted that two other trial courts had also found this patent to be valid and infringed.'newsdesk@afxnews.comwjCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Pfizer wins Norvasc claim over Mylan 